source stringlengths 2 222 | date stringlengths 19 19 | url stringlengths 22 853 ⌀ | text stringlengths 0 10k ⌀ | title stringlengths 0 701 | context_id stringlengths 1 9 | document_id stringclasses 2
values | document_type stringclasses 2
values |
|---|---|---|---|---|---|---|---|
Seeking Alpha | 2018-02-21 00:00:00 | https://seekingalpha.com/article/4148698-best-worst-performing-stocks-earnings-season?source=partner_benzinga | The Best And Worst Performing Stocks On Earnings This Season | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Eddie Staley | 2018-02-16 00:00:00 | https://www.benzinga.com/news/management/18/02/11215788/aceto-names-edward-j-borkowski-cfo | ACETO Names Edward J. Borkowski CFO | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Seeking Alpha | 2018-02-13 00:00:00 | https://seekingalpha.com/news/3330645-energy-materials-top-gainers-losers-2-00-pm?source=partner_benzinga | Energy/Materials - Top Gainers / Losers as of 2:00 pm | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2018-02-07 00:00:00 | https://www.benzinga.com/news/18/02/11149316/aceto-reports-rising-pharma-subsidiary-launched-atenolol-tablets-25mg-50mg-100mg | ACETO Reports Rising Pharma Subsidiary Launched Atenolol Tablets 25mg, 50mg, 100mg | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2018-02-05 00:00:00 | https://www.benzinga.com/news/18/02/11131205/40-biggest-movers-from-friday | 40 Biggest Movers From Friday | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2018-02-02 00:00:00 | https://www.benzinga.com/news/18/02/11127510/mid-afternoon-market-update-crude-oil-down-1-5-natural-grocers-shares-drop-on-ea | Mid-Afternoon Market Update: Crude Oil Down 1.5%; Natural Grocers Shares Drop On Earnings Miss | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Hal Lindon | 2018-02-01 00:00:00 | https://www.benzinga.com/news/guidance/18/02/11122132/aceto-sees-fy-8-adj-eps-1-1-05-vs-1-08-est-sales-growth-10-15 | Aceto Sees FY!8 Adj. EPS $1-$1.05 vs $1.08 Est., Sales Growth 10-15% | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Seeking Alpha | 2018-01-31 00:00:00 | https://seekingalpha.com/news/3326887-notable-earnings-thursday-s-close?source=partner_benzinga | Notable earnings after Thursday's close | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2018-01-02 00:00:00 | https://www.benzinga.com/news/fda/18/01/10973846/aceto-reports-subsidiary-rising-pharma-launched-efavirenz-capsules-50-200mg | ACETO Reports Subsidiary Rising Pharma Launched Efavirenz Capsules, 50, 200mg | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Seeking Alpha | 2017-12-07 00:00:00 | https://seekingalpha.com/news/3317047-aceto-corporation-declares-0_065-dividend?source=partner_benzinga | Aceto Corporation declares $0.065 dividend | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Seeking Alpha | 2017-12-04 00:00:00 | https://seekingalpha.com/news/3316115-energy-materials-top-gainers-losers-2-00-pm?source=partner_benzinga | Energy/Materials - Top Gainers / Losers as of 2:00 pm | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-11-02 00:00:00 | https://www.benzinga.com/news/guidance/17/11/10278468/aceto-sees-fy18-adj-eps-1-05-1-15-vs-1-28-est-sales-growth-15-20 | ACETO Sees FY18 Adj. EPS $1.05-$1.15 vs $1.28 Est., Sales Growth 15-20% | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-10-24 00:00:00 | https://www.benzinga.com/news/17/10/10217031/aceto-reports-rising-pharma-subsidiary-launched-sertraline-oral-solution-20mgml | ACETO Reports Rising Pharma Subsidiary Launched Sertraline Oral Solution, 20mg/ml | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-10-20 00:00:00 | http://www.gurufocus.com/news/582092/aceto-corporation-schedules-first-quarter-fiscal-2018-financial-results-news-release-and-conference-call | ACETO Corporation Schedules First Quarter Fiscal —…–8 Financial Results News Release and ... | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-09-27 00:00:00 | https://www.benzinga.com/news/management/17/09/10110716/aceto-names-william-c-kennally-iii-president-ceo | ACETO Names William C. Kennally, III President, CEO | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Zacks | 2017-08-31 00:00:00 | http://www.zacks.com/stock/news/274095/weakness-seen-in-aceto-corporation-acet-estimates-should-you-stay-away?cid=CS-BENZ-FT-274095 | Weakness Seen in Aceto Corporation (ACET) Estimates: Should You Stay Away? | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2017-08-25 00:00:00 | https://www.benzinga.com/news/17/08/9977759/12-biggest-mid-day-losers-for-friday | 12 Biggest Mid-Day Losers For Friday | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2017-08-24 00:00:00 | https://www.benzinga.com/news/earnings/17/08/9969882/earnings-scheduled-for-august-24-2017 | Earnings Scheduled For August 24, 2017 | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Zacks | 2017-08-22 00:00:00 | http://www.zacks.com/stock/news/272857/zackscom-featured-highlights-appfolio-columbus-mckinnon-concert-pharmaceuticals-aceto-and-liberty-media?cid=CS-BENZ-FT-272857 | Zacks.com featured highlights: AppFolio, Columbus McKinnon, Concert Pharmaceuticals, Aceto and Liberty Media | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Zacks | 2017-08-21 00:00:00 | http://www.zacks.com/stock/news/272636/5-stocks-to-bet-on-new-analyst-coverage?cid=CS-BENZ-FT-272636 | 5 Stocks to Bet on New Analyst Coverage | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-08-11 00:00:00 | http://www.gurufocus.com/news/552775/aceto-corporation-schedules-fourth-quarter--fiscal-2017-financial-results-news-release-and-conference-call | ACETO Corporation Schedules Fourth Quarter & Fiscal —…–7 Financial Results News ... | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2017-07-31 00:00:00 | https://www.benzinga.com/news/17/07/9848889/15-biggest-mid-day-gainers-for-monday | 15 Biggest Mid-Day Gainers For Monday | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-06-20 00:00:00 | https://www.benzinga.com/news/17/06/9629946/aceto-subsidiary-rising-pharmaceuticals-launches-chlorthalidone-tablets-at-multip | ACETO Subsidiary, Rising Pharmaceuticals, Launches Chlorthalidone Tablets At Multiple Dose Ranges | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-05-31 00:00:00 | http://www.gurufocus.com/news/526842/aceto-subsidiary-rising-pharmaceuticals-launches-atomoxetine-capsules-10-18-25-40-60-80--100-mg | ACETO Subsidiary, Rising Pharmaceuticals, Launches Atomoxetine Capsules, –…, –8, —5, ... | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-05-09 00:00:00 | http://www.gurufocus.com/news/518233/alphaone-investment-services-llc-buys-hp-inc-lumentum-holdings-inc-fireeye-inc-sells-cbs-corp-on-semiconductor-corp-vascular-solutions-inc | AlphaOne Investment Services, LLC Buys HP Inc, Lumentum Holdings Inc, FireEye Inc, Sells CBS ... | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Lisa Levin | 2017-05-05 00:00:00 | https://www.benzinga.com/news/17/05/9412921/20-biggest-mid-day-losers-for-friday | 20 Biggest Mid-Day Losers For Friday | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-05-04 00:00:00 | https://www.benzinga.com/news/earnings/17/05/9408001/aceto-q3-eps-0-39-vs-0-44-est-sales-190-1m-vs-195-1m-est | ACETO Q3 EPS $0.39 vs $0.44 Est, Sales $190.1M vs $195.1M Est | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Marketfy Insights | 2017-05-02 00:00:00 | http://marketfy.com/product/dr-stoxx-options-letter/blog/1187/view/120553/ | Buy Aceto Before Earnings - ACET | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Paul Quintaro | 2017-03-31 00:00:00 | https://www.benzinga.com/news/17/03/9241290/aceto-reports-subsidiary-rising-pharma-has-launched-zileuton-er-tablets-600-mg | ACETO Reports Subsidiary, Rising Pharma, Has Launched Zileuton ER Tablets, 600 mg | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-03-28 00:00:00 | http://www.gurufocus.com/news/496502/aceto-subsidiary-rising-pharmaceuticals-launches-capecitabine-tablets-150--500-mg | ACETO Subsidiary, Rising Pharmaceuticals, Launches Capecitabine Tablets, –5… & 5…… mg | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Zacks | 2017-03-06 00:00:00 | http://www.zacks.com/commentary/105556/top-ranked-value-stocks-to-buy-for-march-6th?cid=CS-BENZ-FT-105556 | Top Ranked Value Stocks to Buy for March 6th | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Zacks | 2017-02-28 00:00:00 | http://www.zacks.com/commentary/104990/top-ranked-value-stocks-to-buy-for-february-28th?cid=CS-BENZ-FT-104990 | Top Ranked Value Stocks to Buy for February 28th | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Seeking Alpha | 2017-02-27 00:00:00 | http://seekingalpha.com/article/4050220-new-buffett-inspired-screening-model?source=partner_benzinga | A New Buffett-Inspired Screening Model | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
GuruFocus | 2017-02-23 00:00:00 | http://www.gurufocus.com/news/486722/9-cheap-highyield-stocks | 9 Cheap High-Yield Stocks | ACET | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News | |
Business Wire | 2022-01-10 18:00:00 | https://www.businesswire.com/news/home/20220110006072/en/Tempo-Automation-to-Present-at-the-CJS-Securities-22nd-Annual-New-Ideas-for-the-New-Year-Conference/ | SAN FRANCISCO--(BUSINESS WIRE)--Tempo Automation, Inc. (“Tempo” or the “Company”), a leading software-accelerated electronics manufacturer, today announced that Joy Weiss, Tempo's Chief Executive Officer, and Ryan Benton, the Company's Chief Financial Officer, will participate in the CJS Securities 22nd Annual New Idea... | Tempo Automation to Present at the CJS Securities 22nd Annual New Ideas for the New Year Conference | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-04-27 08:03:00 | https://www.prnewswire.com/news-releases/achronix-and-napatech-partner-to-target-data-center-networking-301277740.html | SANTA CLARA, Calif. and COPENHAGEN, Denmark, April 27, 2021 /PRNewswire/ -- Achronix Semiconductor Corporation, a leader in high-performance FPGAs and embedded FPGA (eFPGA) IP, and Napatech, the leading provider of FPGA-based SmartNICs, today announced a partnership to deliver a new class of high-speed, programmable, F... | Achronix and Napatech Partner to Target Data Center Networking | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-04-27 06:00:00 | https://www.prnewswire.com/news-releases/achronix-and-napatech-partner-to-target-data-center-networking-301277303.html | SANTA CLARA, Calif., April 27, 2021 /PRNewswire/ -- Achronix Semiconductor Corporation, a leader in high-performance FPGAs and embedded FPGA (eFPGA) IP, and Napatech, the leading provider of FPGA-based SmartNICs, today announced a partnership to deliver a new class of high-speed, programmable, FPGA-based SmartNICs to d... | Achronix and Napatech Partner to Target Data Center Networking | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-04-08 16:00:00 | https://www.prnewswire.com/news-releases/achronix-now-shipping-industrys-highest-performance-speedster7t-fpga-devices-301265351.html | SANTA CLARA, Calif., April 8, 2021 /PRNewswire/ -- Achronix Semiconductor Corporation, a leader in high-performance FPGAs and embedded FPGA (eFPGA) IP, today announced that it has begun shipping its 7nm Speedster®7t AC7t1500 FPGAs to customers ahead of schedule. | Achronix Now Shipping Industry's Highest Performance Speedster7t FPGA Devices | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-03-26 16:11:36 | https://investorplace.com/2021/03/churchill-capital-corp-iv-cciv-stock-has-actually-done-investors-proud/ | Churchill Capital Corp. IV lost 20% in the past week. But, CCIV stock has doubled since its July 2020 IPO. | Churchill Capital Corp. IV Has Actually Made Investors Proud | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2021-03-24 12:00:25 | https://seekingalpha.com/article/4415817-acev-and-achronix-offer-exposure-to-high-growth-efpga-story | In January 2021, the Special Purpose Acquisition Corporation (SPAC) ACE Convergence Acquisition Corp. announced intent to acquire Achronix Semiconductor Corp. Since an initial run up, semiconductor supply chain concerns as well as the market rotation from growth to value stocks since have opened a window of opportunity... | ACEV And Achronix Offer Fairly Priced Upside To The Red Hot Semi Market | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-02-12 21:00:00 | https://www.prnewswire.com/news-releases/shareholder-alert-monteverde--associates-pc-announces-an-investigation-of-ace-convergence-acquisition-corp--acev-301227763.html | NEW YORK, Feb. 12, 2021 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a national securities firm rated Top 50 in the 2018 and 2019 ISS Securities Class Action Services Report and headquartered at the Empire State Building in New York City, is... | SHAREHOLDER ALERT: Monteverde & Associates PC Announces an Investigation of ACE Convergence Acquisition Corp. - ACEV | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
GlobeNewsWire | 2021-01-13 13:53:00 | https://www.globenewswire.com/news-release/2021/01/13/2158221/0/en/SHAREHOLDER-ALERT-Rigrodsky-Law-P-A-Announces-Investigation-of-ACE-Convergence-Acquisition-Corp-Merger.html | WILMINGTON, Del., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rigrodsky Law , P.A. announces that it is investigating ACE Convergence Acquisition Corp. (“ACE”) (NASDAQ GS: ACEV) regarding possible breaches of fiduciary duties and other violations of law related to ACE's agreement to merge with Achronix Semiconductor Corporation. | SHAREHOLDER ALERT: Rigrodsky Law, P.A. Announces Investigation of ACE Convergence Acquisition Corp. Merger | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-01-08 17:32:50 | https://investorplace.com/2021/01/top-spac-merger-news-this-week-sofi-clover-health-lion-electric-and-6-more-hot-spacs/ | There was a lot of SPAC merger news for investors to digest this week. For a quick refresher, dive in with InvestorPlace. | Top SPAC Merger News This Week: SoFi, Clover Health, Lion Electric and 6 More Hot SPACs | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
PRNewsWire | 2021-01-07 21:35:00 | https://www.prnewswire.com/news-releases/shareholder-alert-weisslaw-llp-investigates-ace-convergence-acquisition-corp-301203186.html | NEW YORK, Jan. 7, 2021 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of ACE Convergence Acquisition Corp. ("ACEV" or the "Company") (NASDAQ: ACEV) in connection with the Company's proposed merger... | SHAREHOLDER ALERT: WeissLaw LLP Investigates ACE Convergence Acquisition Corp. | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2021-01-07 16:41:00 | https://www.businesswire.com/news/home/20210107005892/en/Achronix-to-List-on-Nasdaq-Through-Merger-With-ACE-Convergence/ | SANTA CLARA, Calif.--(BUSINESS WIRE)--Achronix Semiconductor Corporation, a leader in high-performance field-programmable gate arrays (FPGAs) and embedded FPGA (eFPGA) IP, and ACE Convergence Acquisition Corp. (ACE) (Nasdaq: ACEV), a special-purpose acquisition company, today announced that they have entered into a def... | Achronix to List on Nasdaq Through Merger With ACE Convergence | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2021-01-06 12:22:09 | https://investorplace.com/2021/01/achronix-spac-merger-6-things-to-know-about-the-semiconductor-play-ahead-of-any-ace-deal/ | Achronix Semiconductor is reportedly considering a merger with SPAC ACE Convergence Acquisition (ACEV) that will take it public. The post Achronix SPAC Merger? | Achronix SPAC Merger? 6 Things to Know About the Semiconductor Play Ahead of Any ACE Deal | ACEV | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
seekingalpha.com | 2020-07-12 08:22:16 | https://seekingalpha.com/article/4357979-u-s-ipo-weekly-recap-preclinical-biotech-nkarta-pops-166-in-5-ipo-week | Three biotechs, two Chinese issuers, and one SPAC went public this past week. Preclinical oncology biotech Nkarta popped 166% in the best first-day return for a $10+ million IPO since 2015. | U.S. IPO Weekly Recap: Preclinical Biotech Nkarta Pops 166% In A 5 IPO Week | ACEVU | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
InvestorPlace | 2022-11-18 13:11:37 | https://investorplace.com/2022/11/7-stocks-to-sell-right-now-and-1-to-buy/ | Once again, I drew the short (no pun intended) end of the stick and must discuss stocks to sell right now. Understandably a sensitive topic and one that arouses myriad emotions, I'm just going to stick with the hard numbers. | 7 Stocks to Sell Right Now | ACFN | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-03-31 12:55:05 | https://seekingalpha.com/article/4499023-acorn-energy-inc-s-acfn-ceo-jan-loeb-on-q4-2021-results-earnings-call-transcript | Acorn Energy, Inc.'s (ACFN) CEO Jan Loeb on Q4 2021 Results - Earnings Call Transcript | Acorn Energy, Inc.'s (ACFN) CEO Jan Loeb on Q4 2021 Results - Earnings Call Transcript | ACFN | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-07-17 13:32:14 | https://www.zacks.com/stock/news/2122273/why-arch-capital-acgl-is-poised-to-beat-earnings-estimates-again | Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Why Arch Capital (ACGL) is Poised to Beat Earnings Estimates Again | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-07-05 13:36:35 | https://www.investors.com/research/best-stocks-to-buy-and-watch-insurance-leader-arch-capital-eyes-buy-point-with-accelerating-sales-growth/ | Among the best stocks to buy and watch, insurance leader Arch Capital is approaching a buy point in today's stock market action. | Insurance Leader Arch Capital Eyes Buy Point With Accelerating Sales Growth | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-06-28 16:25:00 | https://www.businesswire.com/news/home/20230627352668/en/Arch-Capital-Group-Ltd.-to-Report-2023-Second-Quarter-Results-on-July-26/ | PEMBROKE, Bermuda--(BUSINESS WIRE)--Arch Capital Group Ltd. (NASDAQ: ACGL) today announced it expects to release its 2023 second quarter results after the close of regular stock market hours on Wednesday, July 26, 2023. The Company will hold a conference call for investors and analysts at 11 a.m. ET on Thursday, July 2... | Arch Capital Group Ltd. to Report 2023 Second Quarter Results on July 26 | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-06-27 14:18:06 | https://www.zacks.com/stock/news/2113802/arch-capital-acgl-up-13-ytd-can-it-retain-the-bull-run | Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position. | Arch Capital (ACGL) Up 13% YTD: Can it Retain the Bull Run? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2023-06-21 14:37:49 | https://www.youtube.com/watch?v=wMUi_CQW8Cg | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: Marriott, Arch Capital & more | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
MarketBeat | 2023-06-07 07:06:09 | https://www.marketbeat.com/originals/dont-overlook-hidden-gem-kinsale-as-rallies-to-new-highs/?SNAPI | Many investors might not get too excited about the insurance business. Still, it's probably worth a reminder that insurance float is a big factor behind the success of Warren Buffett and Berkshire Hathaway Inc. NYSE: BRK.B. | Don't Overlook Hidden Gem Kinsale As Rallies To New Highs | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-30 10:55:48 | https://www.zacks.com/stock/news/2101370/here-s-why-arch-capital-group-acgl-is-a-strong-value-stock | The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage. | Here's Why Arch Capital Group (ACGL) is a Strong Value Stock | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-29 12:20:04 | https://www.zacks.com/stock/news/2101032/arch-capital-acgl-gains-13-ytd-will-the-rally-continue | Arch Capital (ACGL) continues to gain from business opportunities, rate increases, growth in existing accounts and a solid capital position. | Arch Capital (ACGL) Gains 13% YTD: Will the Rally Continue? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-05-26 14:12:22 | https://www.investors.com/research/options/acgl-stock-support-sets-up-high-probability-option-trade/ | A bull put spread takes advantage of time decay and a recent pullback in ACGL to set up a high-probability option trade. | ACGL Stock Support Sets Up High-Probability Option Trade | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Investors Business Daily | 2023-05-12 08:00:59 | https://www.investors.com/etfs-and-funds/sectors/sp500-ten-companies-are-doing-so-well-even-analysts-are-surprised/ | Corporate profits in the S&P 500 are coming in strong. So strong, in fact, that some keep blowing away even the analysts' expectations. | 10 Companies Are Doing So Well Even Analysts Are Amazed | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-10 12:12:12 | https://www.zacks.com/stock/news/2093555/here-s-why-hold-strategy-is-apt-for-arch-capital-acgl | Arch Capital (ACGL) stands to gain from new business opportunities, rate increases, strategic acquisitions and a solid capital position. | Here's Why Hold Strategy is Apt for Arch Capital (ACGL) | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-05-04 19:44:45 | https://www.zacks.com/stock/news/2090444/3-finance-stocks-displaying-relative-strength | While concerns around regional banking are more than valid, not all pockets of the Finance sector have been weak, including shares of these three companies. | 3 Finance Stocks Displaying Relative Strength | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-27 15:11:03 | https://www.zacks.com/stock/news/2086369/arch-capital-acgl-q1-earnings-and-revenues-top-rise-y-y | Arch Capital (ACGL) Q1 results reflect improved premiums and higher net investment income on the back of improved Insurance and Reinsurance segment performance. | Arch Capital (ACGL) Q1 Earnings and Revenues Top, Rise Y/Y | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-26 23:31:07 | https://www.zacks.com/stock/news/2085578/arch-capital-acgl-reports-q1-earnings-what-key-metrics-have-to-say | While the top- and bottom-line numbers for Arch Capital (ACGL) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values. | Arch Capital (ACGL) Reports Q1 Earnings: What Key Metrics Have to Say | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-26 20:30:31 | https://www.zacks.com/stock/news/2085521/arch-capital-group-acgl-beats-q1-earnings-and-revenue-estimates | Arch Capital Group (ACGL) came out with quarterly earnings of $1.73 per share, beating the Zacks Consensus Estimate of $1.51 per share. This compares to earnings of $1.10 per share a year ago. | Arch Capital Group (ACGL) Beats Q1 Earnings and Revenue Estimates | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-25 08:24:17 | https://www.zacks.com/stock/news/2083862/why-earnings-season-could-be-great-for-arch-capital-acgl | Arch Capital (ACGL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Why Earnings Season Could Be Great for Arch Capital (ACGL) | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-21 12:10:11 | https://www.zacks.com/stock/news/2082903/will-arch-capital-s-acgl-beat-streak-continue-in-q1-earnings | Arch Capital's (ACGL) first-quarter 2023 earnings are likely to reflect growth in most lines of business as well as in existing accounts, gain in invested assets and higher yields, offset by higher expenses. | Will Arch Capital's (ACGL) Beat Streak Continue in Q1 Earnings? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-17 09:54:11 | https://www.zacks.com/stock/news/2079520/these-2-finance-stocks-could-beat-earnings-why-they-should-be-on-your-radar | Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates. | These 2 Finance Stocks Could Beat Earnings: Why They Should Be on Your Radar | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-04-12 13:42:19 | https://www.zacks.com/stock/news/2077707/will-arch-capital-acgl-beat-estimates-again-in-its-next-earnings-report | Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-31 11:31:15 | https://www.zacks.com/stock/news/2072964/arch-capital-group-acgl-is-a-top-ranked-growth-stock-should-you-buy | Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service. | Arch Capital Group (ACGL) is a Top-Ranked Growth Stock: Should You Buy? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-03-30 16:04:00 | https://www.businesswire.com/news/home/20230330005674/en/Arch-Capital-Group-Ltd.-to-Report-2023-First-Quarter-Results-on-April-26/ | PEMBROKE, Bermuda--(BUSINESS WIRE)--Arch Capital Group Ltd. (NASDAQ: ACGL) today announced it expects to release its 2023 first quarter results after the close of regular stock market hours on Wednesday, April 26, 2023. The Company will hold a conference call for investors and analysts at 11 a.m. Eastern Time on Thursd... | Arch Capital Group Ltd. to Report 2023 First Quarter Results on April 26 | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-23 11:28:10 | https://www.zacks.com/stock/news/2069625/are-finance-stocks-lagging-arch-capital-group-acgl-this-year | Here is how Arch Capital Group (ACGL) and BrightSphere Investment Group (BSIG) have performed compared to their sector so far this year. | Are Finance Stocks Lagging Arch Capital Group (ACGL) This Year? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-20 12:59:43 | https://www.zacks.com/stock/news/2068037/arch-capital-acgl-rallies-34-in-a-year-more-room-to-run | New business opportunities, rate increases, growth in existing accounts and a solid capital position continue to drive Arch Capital (ACGL). | Arch Capital (ACGL) Rallies 34% in a Year: More Room to Run? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-15 13:00:33 | https://www.zacks.com/stock/news/2066204/why-is-arch-capital-acgl-up-1-6-since-last-earnings-report | Arch Capital (ACGL) reported earnings 30 days ago. What's next for the stock? | Why Is Arch Capital (ACGL) Up 1.6% Since Last Earnings Report? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-14 10:43:44 | https://www.zacks.com/stock/news/2065296/5-discounted-value-picks-based-on-peg-ratio | Here are five stocks that pass our screening criteria. These are HSIC, KR, BIDU, TOL and ACGL. | 5 Discounted Value Picks Based on PEG Ratio | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-07 11:17:43 | https://www.zacks.com/stock/news/2062575/is-arch-capital-group-acgl-stock-outpacing-its-finance-peers-this-year | Here is how Arch Capital Group (ACGL) and Axis Capital (AXS) have performed compared to their sector so far this year. | Is Arch Capital Group (ACGL) Stock Outpacing Its Finance Peers This Year? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-03-01 09:02:22 | https://www.zacks.com/stock/news/2060258/5-best-peg-driven-garp-stocks-to-grab-now | Here are the five GARP stocks that qualify our screening criteria -- META, HSIC, ADI, HSBC, ACGL. | 5 Best PEG-Driven GARP Stocks to Grab Now | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-22 13:33:07 | https://www.zacks.com/stock/news/2057617/can-arch-capital-acgl-run-higher-on-rising-earnings-estimates | Arch Capital (ACGL) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions. | Can Arch Capital (ACGL) Run Higher on Rising Earnings Estimates? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-21 13:33:12 | https://www.zacks.com/stock/news/2057029/here-s-why-you-should-hold-rli-stock-in-your-portfolio-now | Strong branch office network, diversified portfolio, improving segmental revenues and solid capital position poise RLI well for growth. | Here's Why You Should Hold RLI Stock in Your Portfolio Now | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-20 11:17:58 | https://www.zacks.com/stock/news/2056375/reasons-why-arch-capital-acgl-stock-is-an-attractive-pick | Arch Capital (ACGL) stands to gain from solid segmental performances, strategic acquisitions and effective capital deployment. | Reasons Why Arch Capital (ACGL) Stock Is an Attractive Pick | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-17 13:33:27 | https://www.zacks.com/stock/news/2056050/arch-capital-group-acgl-is-up-4-83-in-one-week-what-you-should-know | Does Arch Capital Group (ACGL) have what it takes to be a top stock pick for momentum investors? Let's find out. | Arch Capital Group (ACGL) Is Up 4.83% in One Week: What You Should Know | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-16 14:18:10 | https://www.zacks.com/stock/news/2055556/looking-for-a-growth-stock-3-reasons-why-arch-capital-acgl-is-a-solid-choice | Arch Capital (ACGL) possesses solid growth attributes, which could help it handily outperform the market. | Looking for a Growth Stock? 3 Reasons Why Arch Capital (ACGL) is a Solid Choice | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-16 11:19:07 | https://www.zacks.com/stock/news/2055283/are-finance-stocks-lagging-arch-capital-group-acgl-this-year | Here is how Arch Capital Group (ACGL) and BrightSphere Investment Group (BSIG) have performed compared to their sector so far this year. | Are Finance Stocks Lagging Arch Capital Group (ACGL) This Year? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-16 11:19:01 | https://www.zacks.com/stock/news/2055276/is-arch-capital-group-acgl-a-great-value-stock-right-now | Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks. | Is Arch Capital Group (ACGL) a Great Value Stock Right Now? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-02-14 15:40:19 | https://seekingalpha.com/article/4578277-arch-capital-group-ltd-acgl-q4-2022-earnings-call-transcript | Arch Capital Group Ltd. (NASDAQ:ACGL ) Q4 2022 Results Conference Call February 14, 2023 11:00 AM ET Company Participants Marc Grandisson - CEO Francois Morin - CFO Conference Call Participants Tracy Benguigui - Barclays Michael Zaremski - BMO Jamminder Bhullar - JPMorgan Brian Meredith - UBS Yaron Kinar - Jefferies Ry... | Arch Capital Group Ltd. (ACGL) Q4 2022 Earnings Call Transcript | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-14 15:03:07 | https://www.zacks.com/stock/news/2054268/arch-capital-acgl-q4-earnings-top-on-reinsurance-strength | Arch Capital's (ACGL) Q4 results reflect improved premiums and higher net investment income on the back of improved Insurance and Reinsurance segment performance. | Arch Capital (ACGL) Q4 Earnings Top on Reinsurance Strength | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-13 19:34:36 | https://www.zacks.com/stock/news/2053677/arch-capital-group-acgl-beats-q4-earnings-and-revenue-estimates | Arch Capital (ACGL) delivered earnings and revenue surprises of 59.70% and 10.28%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? | Arch Capital Group (ACGL) Beats Q4 Earnings and Revenue Estimates | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-10 09:47:07 | https://www.zacks.com/stock/news/2052810/here-s-what-to-expect-from-arch-capital-s-acgl-q4-earnings | Arch Capital's (ACGL) Q4 earnings are likely to reflect new business opportunities, rate increases and positive cash flow from operations, offset by higher expenses and cat loss. | Here's What to Expect From Arch Capital's (ACGL) Q4 Earnings | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-09 13:34:09 | https://www.zacks.com/stock/news/2052500/will-arch-capital-acgl-beat-estimates-again-in-its-next-earnings-report | Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-09 09:48:32 | https://www.zacks.com/stock/news/2052197/why-arch-capital-acgl-might-surprise-this-earnings-season | Arch Capital (ACGL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season. | Why Arch Capital (ACGL) Might Surprise This Earnings Season | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-02-07 10:33:43 | https://www.zacks.com/stock/news/2050875/why-investors-need-to-take-advantage-of-these-2-finance-stocks-now | Investors looking for ways to find stocks that are set to beat quarterly earnings estimates should check out the Zacks Earnings ESP. | Why Investors Need to Take Advantage of These 2 Finance Stocks Now | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2023-01-17 17:29:58 | https://seekingalpha.com/article/4570442-arch-capital-group-positive-momentum-and-earnings-trends | Insurance stocks have notched all-time highs. One high-momentum name is a favorite among sell side analysts, and it recently replaced Twitter in the S&P 500. | Arch Capital Group: Positive Momentum And Earnings Trends | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-13 11:18:24 | https://www.zacks.com/stock/news/2039069/arch-capital-acgl-up-35-in-a-year-more-room-for-upside | New business opportunities, rate increases, growth in existing accounts and a solid capital position continue to drive Arch Capital (ACGL). | Arch Capital (ACGL) Up 35% in a Year: More Room for Upside? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Business Wire | 2023-01-09 16:05:00 | https://www.businesswire.com/news/home/20230109005632/en/Arch-Capital-Group-Ltd.-to-Report-2022-Fourth-Quarter-Results-on-Feb.-13-2023/ | PEMBROKE, Bermuda--( BUSINESS WIRE )--Arch Capital Group Ltd. (NASDAQ: ACGL) today announced it expects to release its 2022 fourth quarter results after the close of regular stock market hours on Monday, Feb. 13, 2023. The Company will hold a conference call for investors and analysts at 11 a.m. ET on Tuesday, Feb. 14,... | Arch Capital Group Ltd. to Report 2022 Fourth Quarter Results on Feb. 13, 2023 | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2023-01-09 13:33:11 | https://www.zacks.com/stock/news/2036914/will-arch-capital-acgl-beat-estimates-again-in-its-next-earnings-report | Arch Capital (ACGL) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report. | Will Arch Capital (ACGL) Beat Estimates Again in Its Next Earnings Report? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-12-29 13:04:32 | https://seekingalpha.com/article/4566935-arch-capital-insurance-solutions | 100% technical buy signals. 10 new highs and up 8.34% in the last month. | Arch Capital: Insurance Solutions | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-12-15 12:02:14 | https://www.zacks.com/stock/news/2029203/why-should-you-stay-invested-in-arch-capital-acgl-stock | New business opportunities, rate increases, growth in existing accounts and solid capital position poise Arch Capital (ACGL) for growth | Why Should You Stay Invested in Arch Capital (ACGL) Stock? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
CNBC Television | 2022-12-05 14:54:13 | https://www.youtube.com/watch?v=PLRolZgsQoI | The "Halftime Report" traders give their top picks to watch for the second half. | Final Trades: Dupont, Deere, Rockwell Automation & more | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Zacks Investment Research | 2022-11-16 12:02:10 | https://www.zacks.com/stock/news/2018991/arch-capital-acgl-up-26-ytd-will-the-bull-run-continue | New business opportunities, rate increases, growth in existing accounts and solid capital position continue to drive Arch Capital (ACGL). | Arch Capital (ACGL) Up 26% YTD: Will the Bull Run Continue? | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Seeking Alpha | 2022-11-04 02:43:34 | https://seekingalpha.com/article/4553024-arch-capital-group-q3-2022-earnings-hold | Arch Capital generates an earnings beat for the third time out of the last four quarters. Replacing Twitter in the S&P 500 is a positive catalyst for the company, which jumped 8 percent on the news. | Arch Capital Group: Performing Well In A Difficult Environment | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Benzinga | 2022-10-28 15:26:09 | https://www.benzinga.com/trading-ideas/movers/22/10/29465022/why-arch-capital-group-shares-are-popping-off-friday-following-elon-musks-twitter-acquisitio?SNAPI | Arch Capital Group Ltd. (NASDAQ: ACGL) shares are trading higher by 10.01% to $56.86 going into the close of Friday's trading session after it was announced the company is set to join the S&P 500. | Why Arch Capital Group Shares Are Popping Off Friday Following Elon Musk's Twitter Acquisition - Arch Capital Group (NASDAQ:ACGL) | ACGL | 1422a02c-0b5b-47f4-8011-863bf51d1a96 | News |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.